BIO.News Newsletter

A small biotech tells the FTC how M&As can help advance innovation for patients—and a rise in bird flu, including in the U.S., tells us that it’s time to advance gene editing and One Health. (591 words, 2 minutes, 57 seconds)

Back to work—and we take a deeper dive into why we don’t need the COVID vaccine waiver. Meanwhile, extreme heat is killing cows in Kansas—but the FDA’s already given the green light to a biotech solution for cattle welfare. (695 words, 3 minutes, 28 seconds)

On Friday, the WTO agreed to a waiver of COVID vaccine intellectual property protections—here’s what we know. And while it’s a federal holiday in DC (and for BIO) for Juneteenth, we want to take a moment to look at why this day is an important reminder of the need for diversity, equity, and inclusion in health care and our industry. (733 words, 3 minutes, 39 seconds)

FDA Commissioner Dr. Robert M. Califf joined the final day of BIO International Convention—here’s what he said about Accelerated Approval, misinformation, and the things the agency does other than drugs. (776 words, 3 minutes, 52 seconds)

Day 3 of the BIO International Convention put a focus on Accelerated Approval—including its value and why it matters for patients. We also heard from patient advocates including the great Venus Williams about why patients’ stories are so important. (724 words, 3 minutes, 37 seconds)

We have new reports on VC funding for biotech and the value of federally funded research—plus, what happened during the Senate HELP Committee’s markup of FDA user fee legislation and more news from Day 2 of BIO International Convention. (842 words, 4 minutes, 12 seconds)

The theme of BIO Convention Day #1 was the importance of inclusion—from within companies, to the products we create, to ensuring access to clinical trials and innovation. Here’s what we learned—about how to measure and report DEI and ESG, why it’s a great time to invest in women’s health, plus more news from San Diego and inside the Beltway. (658 words, 3 minutes, 17 seconds)

The BIO International Convention is here—in person! We kick off with an exclusive preview of BIO’s diversity report, a forthcoming book on the orphan drug revolution, and how to follow our coverage—including our Good Day BIO LIVE! morning news show. All of that plus today’s news below. (928 words, 4 minutes, 38 seconds)

Before we head to the BIO International Convention, we have news on inflation and health care costs, the FTC’s plans to investigate pharmacy middlemen, and booming life sciences job growth. And be sure to check your inbox on Monday morning—we’ll be coming to you live from San Diego with something special! In the meantime, you can follow along on bio.news. (695 words, 3 minutes, 28 seconds)

The House passed FDA user fee reauthorization yesterday, which will help fund FDA research to bring more breakthroughs to patients. We have details and what’s next in the Senate. And with a soil shortage looming, a study finds regenerative farming can boost soil health and food nutrition. Plus, nominations are open for BIO’s George Washington Carver and Rosalind Franklin Awards – details below. (915 words, 4 minutes, 34 seconds)